pediatric cough cme

Upload: kurutala

Post on 04-Jun-2018

235 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/14/2019 Pediatric Cough CME

    1/59

    Role of cough syrups and anti-pyretics in treatment of pediatric

    cough: Children are not miniature

    adults

  • 8/14/2019 Pediatric Cough CME

    2/59

    Cough is a very elaborate act with the explicitintention of expelling irritants in the

    respiratory tract

    The irritants may be intrinsic eg. Mucus & phlegm

    or extrinsic eg. Foreign particle or body

    Cough is reflex-evoked modification of breathing pattern in

    response to airway irritation

    Cough can also be produced voluntarily

    Why do we cough?

  • 8/14/2019 Pediatric Cough CME

    3/59

    How do we cough?

    The event of cough is deep inspiration followed by forceful expulsion

    Diaphragm and external intercostal muscles contract, creating a negative

    pressure around the lung.Air rushes into the lungs

    The glottis closes and the vocal cords contract to shut the larynx.

    The abdominal muscles contract to accentuate the action of the relaxing

    diaphragm; simultaneously, the other expiratory muscles contractincrease the pressure of air within the lungs upto 300mmHg.

    The vocal cords relax &the glottis opensreleasing air at over 100mph.

    The bronchi and non-cartilaginous portions of the trachea collapse to

    form slits through which the air is forced, which clears out any irritantsattached to the respiratory lining.

    However mechanical laryngeal stimulation as in aspiration results in

    immediate expiratory stimulation without the preceding inspiratory

    phase to protect the airway from aspiration by expiratory reflex.

  • 8/14/2019 Pediatric Cough CME

    4/59

    How do we cough?

    Each cough occurs through the stimulation of acomplex reflex arc constituted by:

    Afferent pathway: Sensory nerve fibers located in theciliated epithelium of the upper airways, branchesfrom the diaphragm. The afferent impulses go to themedulla diffusely.

    Central Pathway : a central coordinating region forcoughing is located in the upper brain stem and pons.

    Efferent pathway: Impulses from the cough centertravel via the vagus, phrenic, and spinal motor nervesto diaphragm, abdominal wall and intercostal muscles.

  • 8/14/2019 Pediatric Cough CME

    5/59

    How do we cough?

    This is initiated by the stimulation of

    cough receptors which are found in the

    trachea, main carina, branching points of

    large airways, and more distal smaller

    airways, the pharynx, external auditory

    canals, eardrums, paranasal sinuses,

    pharynx, diaphragm, pleura, pericardium,

    and stomach.

    The receptors are mechano-recptors

    stimulated by irritation by mucus plug,

    foreign body, particulate matter etc or

    chemorecptors stimulated by irritants,

    fumes, aspirates,The afferent neural pathway is through the

    internal Laryngeal branch of the Superior

    Laryngeal branch of the Vagus.

    The efferent neural pathway is mediated

    through the Vagus, Phrenic nerve & theIntercostal nerves

  • 8/14/2019 Pediatric Cough CME

    6/59

    NOT SMALL ADULTS(CAUTION WITH EXTRAPOLATING ADULT LITERATURE)

    Viruses responsible for common cold in adults may cause seriousrespiratory illness in kids.

    Maturational differences in airway anatomy, respiratory

    musculature, chest wall structure. Differences in medication response.

    Medical history in young kids is limited by parental perception andavailability.

    Children should be managed according to the studies and guidelines forchildren (when available), because etiologic factors and treatments inchildren are sometimes different from those in adults.

  • 8/14/2019 Pediatric Cough CME

    7/59

    DIAGNOSTIC APPROACHES

    Children with chronic cough require careful and systematicevaluation for the presence of specific diagnostic indicators.

    In children with chronic cough, the etiology should be defined andtreatment should be etiologically based.

    Children with chronic productive purulent cough should always beinvestigated to document the presence or absence of bronchiectasisand to identify underlying and treatable causes such as cystic fibrosisand immune deficiency.

    History and physical exam first:

    Specific pointerssuggestive of specific cough.

  • 8/14/2019 Pediatric Cough CME

    8/59

    DIAGNOSTIC APPROACHES

    Pointers to the Presence of Specific Cough

    Auscultatory findings, wheeze, crepitations

    Cardiac abnormalities

    Chest pain

    Chest wall deformity

    Digital clubbing, FTT (CF)

    Neurodevelopmental (potential for aspiration)

    In children with nonspecific cough, cough may spontaneously

    resolve, but children should be reevaluated for the emergence

    of specific etiologic pointers.

  • 8/14/2019 Pediatric Cough CME

    9/59

    DIAGNOSTIC APPROACHES

  • 8/14/2019 Pediatric Cough CME

    10/59

    DIAGNOSTIC APPROACHES

    12yo male with remote history of URI has been coughing since

    Thanksgiving.

    Children with chronic cough should undergo, as a minimum, CXR and

    spirometry, if age appropriate.

    CXR quick, readily attainable.

    Spirometry reliably performed in kids > 6 yrs (often >3 yrs, with

    appropriate personnel).

  • 8/14/2019 Pediatric Cough CME

    11/59

    DIAGNOSTIC APPROACHES

    Also considered: Chest or sinus CT

    a.) HRCT as current gold standard for eval of small airwayanatomy.

    b.) Lifetime cancer risk is age and dose dependent.c.) Single Chest CT scan ~ 5.8 mSv (CXR ~ 0.02 mSv, so =300 CXRs).

    Flexible bronchoscopy

    1.) suspicion of airway abnormality.2.) localized radiology changes.3.) suspicion of inhaled foreign body.4.) eval of aspiration lung disease.

    5.) micro studies and lavage (BAL).

  • 8/14/2019 Pediatric Cough CME

    12/59

    ETIOLOGY

    In children with specific cough, further investigations may be

    warranted, except when asthma is the etiologic factor.

    Cough is the most common presenting symptom in patients

    presenting to doctors in US and Australia.

    Viral URIs, which also cause cough, are said to account for 80

    percentof childhood asthma exacerbations.

    7yo female with known RAD presents withcough and wheezing.

  • 8/14/2019 Pediatric Cough CME

    13/59

    ETIOLOGY

    Upper Airway Disorders and Cough

    Upper airway cough syndrome (aka post-nasal drip) well

    documented in adults.

    In children, relationship between nasal secretions and cough ismore likely linked by common etiology (infection or

    inflammation).

    Abnormal sinus radiographs found in 18-82% of

    asymptomatic children.

    No RCTs on therapies for upper airway disorders in kids with

    improvement of nonspecific cough as outcome measurement.

  • 8/14/2019 Pediatric Cough CME

    14/59

    ETIOLOGY

    GERD and Cough

    PROOF that GERD causes chronic cough in kids is rare.

    Infants often regurgitate, but few well infants cough with these

    episodes. Available prospective studies of chronic cough in kids suggest

    that GERD is infrequently the SOLE cause.

  • 8/14/2019 Pediatric Cough CME

    15/59

    ETIOLOGY

    Airway Lesions and Cough

    Prevalence of airway lesions found in asymptomatic children

    is unknown.

    Relationship of cough to airway lesion can only be postulated: Airway malacia impedes clearance of secretions; potential for

    pneumonic process distal to lesion

  • 8/14/2019 Pediatric Cough CME

    16/59

    ETIOLOGY

    Environmental Pulmonary Toxicants

    Increases susceptibility to respiratory infections

    Increases coughing illnesses

    Close association to tobacco smoke exposure, especially inassociation with asthma.

    15yo female with cough for past month, noticed by parents

    that only occurs after home from school.

    In all children with cough, exacerbating factors such as ETS exposure

    should be determined and interventional options for the cessation of

    exposure advised and initiated.

  • 8/14/2019 Pediatric Cough CME

    17/59

    ETIOLOGY

    Chronic Nocturnal Cough

    Unreliability and inconsistency of reporting.

    Often used as a direct indicator of asthma.

    Community based study revealed only a third of children withisolated nocturnal cough had asthma.

    No studies that objectively document that nocturnal cough is

    worse than daytime cough in uncontrolled asthmatics.

  • 8/14/2019 Pediatric Cough CME

    18/59

    ETIOLOGY

    Respiratory Infections and Postinfectious Cough

    Postviral cough refers to presence of cough after acute viral

    URI. Unstudied natural history beyond 25 days.

    Re-infection (when not completely recovered) may result inappearance of prolonged coughing.

    Total respiratory illnesses per person year ranges 5-8/yr

    (

  • 8/14/2019 Pediatric Cough CME

    19/59

    ETIOLOGY

    Psychogenic Cough

    AKA habit cough, tic cough, psychogenic cough.

    Behaviorial association.

    Inhalation of Foreign Body

    Presentations usually acute, but chronic cough may be

    presenting symptom of missedFB inhalation.

    Normal CXR does not exclude. Specific history should be sought.

  • 8/14/2019 Pediatric Cough CME

    20/59

    ETIOLOGY

    Parental Expectations

    Parental expectations as well as the doctors perceptions (of said

    expectations) influences consulting rates and prescription use.

    Use of OTC meds and frequency of doctors visits were less

    likely with more highly educated mothers.

    Parental concerns can be extreme and include fear of child

    choking and dying, SIDS, asthma attack, permanent chest

    damage.

    In children with nonspecific cough, parental expectations should be

    determined, and the specific concerns of the parents should be sought and

    addressed.

  • 8/14/2019 Pediatric Cough CME

    21/59

    Types of coughs

    Dry or non productive cough

    Phlegmy or productive cough

    Croupy or barking cough Cough with wheezing

    Pertussis or cough with a whoop

    GERD or cough with choking

  • 8/14/2019 Pediatric Cough CME

    22/59

    Dry or nonproductive coughShort bursts of incessant cough

    Occurs daytime as well as nighttime

    Associated with hoarseness of voice, pain while swallowing and

    on external pressure

    Nocturnal dry cough is aggravated in supine position due to post

    nasal dripAcute dry cough is caused by upper respiratory infections due to

    virus including Flu virus, bacterial infections including

    Streptococcus, H Influenzae and Chlamydia

    Chronic dry cough could be due to enlarged tonsils, adenoidswith post nasal drip or intraluminal or extraluminal obstruction in

    upper airway eg. Endobronchial/ paratracheal LNs

    Pharyngeal irritation directly is unlikely to induce cough because the innervation is

    Glossophayngeal & not vagus.

  • 8/14/2019 Pediatric Cough CME

    23/59

    Phlegmy or Productive cough

    Productive cough is due to catarrh due excessive

    production or non clearance of mucus from upper/ lowerairway

    It could be infective or noninfective

    Infective productive cough could be due to infection in

    upper airway as in paranasal sinusitis or lower airway as in

    pneumonia or bronchiectasis

    Non infective productive cough could be due to allergic

    catarrh or due to thick tenacious phlegm as in cysticfibrosis

    Cough is seen daytime as well as night time

  • 8/14/2019 Pediatric Cough CME

    24/59

    Croup or barking cough

    Sudden onset spasmodic non productive cough with a barkingquality

    Mostly occurs in early half of night

    Mostly occurs in children below 3 years of age

    Generally preceded by mild corryza with/ without fever of shortduration

    Although dramatic in onset & presentation, child doesnt appear

    toxic or in pain or distress. No dysphagia.

    Very few children have recurrences till age of 3 years.X-ray neck AP view shows subglottic narrowing of airway:

    Steeple sign

    Toxic child with dysphagia, dysphonia should have X-ray neck

    Lateral view to r/o epiglottitis which is a medical emergency.

  • 8/14/2019 Pediatric Cough CME

    25/59

    Pertussis or cough with a whoop

    Prolonged cough with short outbursts of cough ending

    with asound of whoop

    Lasts from a few weeks to months even after specific

    treatment with appropriate antibiotics.

    Severity of cough esp in small infants can lead toconjunctival , oral mucosal bleed, intracranial bleed

    can lead to convulsions or loss of cosciousness.

    A bout of cough may lead to severe vomiting as wellas poor intake of food, leading to malnutrition

    GERD h ith h ki

  • 8/14/2019 Pediatric Cough CME

    26/59

    GERD or cough with choking

    Coughing associated with feeding events

    More common in supine feeding- more in bottle-fed than breast fed

    infants.Occurs in neonates and may continue till late infancy when child starts

    to feed in sitting position esp semisolid & solid feeds

    Typically starts within few minutes of feeding with mild clearing throat

    sounds leading to head bobbing followed by bout of vomiting or coughas mouth fills with milk rising from the esophagus. Head bobbing may

    even lead to retraction of neck .

    Severity of GERD is classified in terms of frequency as well as degree of

    reflux.It occurs due to physiological laxity of lower esophageal sphincter with

    acidic stomach contents coming into esophagus

    The cough is due to stimulation of chemoreceptors in the distal airway & Vagal

    innervated receptors in the esophagus

  • 8/14/2019 Pediatric Cough CME

    27/59

    Why should we treat cough?

    It is obvious that the process of cough is beneficial andhelps to clear mechanical or chemical irritants in the

    respiratory tract.

    However the large pressures & velocities generated in the

    airways are also responsible for many of the complicationsof cough, including hoarseness, excessive perspiration,

    urinary incontinence, rib fractures, musculoskeletal pain,

    exhaustion, headache, dizziness & self-consciousness.

    The nocturnal cough with/ without post nasal drip leaves the

    child insomnic with daytime somnolescence & hyperkinetic

    behavior.

  • 8/14/2019 Pediatric Cough CME

    28/59

    Choice of cough medications

    The purpose of cough medications is alleviation of

    symptoms.They are always add-ons to specific medications such as

    Antibiotics, Bronchodilators, antiallergics eg

    antihistaminic & interleukin receptors inhibitors egMontleukast or anti-inflammatory eg steroids

    Cough medications are given as cough suppressants,

    decongestants, expectorants & mucolytics.

    They are available as tablets, syrups or lozenges

  • 8/14/2019 Pediatric Cough CME

    29/59

    Cough suppressants

    Cough suppressants prevent or stop coughing

    Cough suppressants cross the blood brain barrier &

    act on the center in the medulla that controls the

    cough reflex i.e. they act centrally

    They are narcotic derived e.g. Codein, pholcodein,Noscapine and non addictive narcotic like

    Dextromethorphan or non narcotic like Benzonatate

    They are useful to suppress dry cough, nocturnalcough and pertussis.

    They are prone to be abused

    They are not safe below 6 years of age.

  • 8/14/2019 Pediatric Cough CME

    30/59

    Cough suppressants Dextromethorphan is the commonest cough suppressant

    available either alone or in combination with antihistamines ordecongestants

    Derived from morphine, it is a narcotic antitussive but has noanalgesic or addictive property

    Although it is as effective as Codein as an antitussive inadults, its efficacy is no better than placebo

    Although it is non addictive in therapeutic dose , in very highdose it is used for recreation and is prone to be abused.

    Dosage: 0.5 mg/kg/dose 3-4 times a day Codein: Centrally acting narcotic antitussive available either

    alone or in combination with antihistmines.

    Dosage: 0.3mg/kg/dose 2-3 times/day

    Noscapine: Non addictive narcotic antitussive.

  • 8/14/2019 Pediatric Cough CME

    31/59

    Mucokinetic agentsThese are various agents which help to keep the mucus

    thin and helps the mucociliary mechanism to expelthe thick mucus.Act on the afferent wing of cough reflex, either as:

    Expectorants : stimulate body to hydrate & thin the

    mucus eg. Guiphenesine

    Mucolytic agent: Helps to make mucus thin e.g. oralCarbocystein, Ambroxol, Bromhexine or inhaled

    acetylcysteine. Adhesives / surfactants: Reduces affinity between

    secretions & biological surfaces eg. Ammoniumchloride, potassium iodide

  • 8/14/2019 Pediatric Cough CME

    32/59

    Combination cough medicationsCommon available combinations:

    Antitussive + Antihistamine

    Decongestant + Antihistamine

    Decongestant + Mucolytic

    Expectorant + Mucolytic Expectorant + Antiadhesive

    Expectorants + Brochodilator

    Combinations that should be banned

    Montlukast + Expectorants

    Expectorants + Zinc / Calcium

    Mucolytic + Amoxycillin

  • 8/14/2019 Pediatric Cough CME

    33/59

    Herbal medicines & Home

    remedies

    Mostly cough suppressants act as demulsifying

    agents soothing for throat

    Contain various combinations of honey, tulsi,

    ginger, methi.

    Recent preparations with dry ivy leaf extract

    Give temporary relief

    Do not treat underlying cause

    Generally safe & non addictive

  • 8/14/2019 Pediatric Cough CME

    34/59

    Fever

    Elevation of body temperature above normal range of 36.5

    37.5 C (98100 F) due to elevated temperature regulatory

    set point is fever.

    Elevation of body temperature greater than or equal to 41.5

    C (106.7 F) due to elevated temperature regulatory centreis hyperpyrexia which is fever.

    Elevation of body temperature without elevated temperature

    regulatory set point as in elevated environmental

    temperature or heat stroke is hyperthermia

    In hyperthermia the body temperature rises above its set point &hence is notfever!

  • 8/14/2019 Pediatric Cough CME

    35/59

    Thermoregulatory mechanism

    The brain orchestrates heat effector mechanisms

    via the Autonomous Nervous system:

    Increased heat production:

    by increased muscle tone, shivering

    hormones like epinephrine

    Prevention of heat loss

    vasoconstriction.

    This temperature regulation is controlled in the hypothalamus

    Thermoreg lator centre & afferent & efferent arms

  • 8/14/2019 Pediatric Cough CME

    36/59

    Thermoregulatory centre & afferent & efferent arms

    The preoptic region, in & near

    the rostral hypothalamus,acts as a coordinating center.

    The preoptic area contains

    neurons that are sensitive to

    subtle changes in hypothalamicor core temperature & also

    receive somatosensory

    input from spinal & skin

    thermoreceptors & integrate

    central and peripheral thermal

    information

    M h i f f

  • 8/14/2019 Pediatric Cough CME

    37/59

    Mechanism of fever

    Fever & Hyperpyrexia result from elevation of

    thermoregulatory set point in response to chemicalmediators called pyrogens.

    Pyrogens are generally immune mediated cytokines

    eg. IL 1, IL 6, TNF generally released frommacrophages engulfing various pathogens.

    These cytokines then bind with endothelial receptors on

    vessel walls activating the arachidonic acid

    pathwayformation of PGE2mediator of fever(COX2)

    by acting on the preoptic area of hypothalamusfever response

    Body responses to temperature variations

  • 8/14/2019 Pediatric Cough CME

    38/59

    Body responses to temperature variationsEffector Response to low temperature Response to high temperature

    Smooth

    muscles in

    arterioles in

    the skin.

    Muscles contractVasoconstriction.

    Extremities can turn blue and feel cold and

    can even be damaged (frostbite).

    Muscles relaxvasodilation. More

    heat is carried from the core to the

    surfacelost by convection & Skinturns red.

    Sweat glands No sweat produced. Glands secrete sweat onto surface

    of skinevaporates, it takes heat

    from the body

    Erector pili

    muscles in

    skin

    Muscles contract, raising skin hairs and

    trapping an insulating layer of still, warm

    air next to the skin.

    Muscles relax, lowering the skin hairs

    and allowing air to circulate over the

    skin convection and evaporation.

    Skeletal

    muscles

    Shivering: Muscles contract & relax

    repeatedly, generating heat by friction &

    metabolic reactions

    No shivering.

    Adrenal &

    thyroid glands

    Glands secrete adrenaline and thyroxine

    respectivelyincreases the metabolic rate

    in different tissues generating heat.

    Glands stop secreting adrenaline &

    thyroxine.

    Behavior Curling up, huddling, finding

    shelter, putting on more clothes.

    Stretching out, finding shade,

    removing clothes

  • 8/14/2019 Pediatric Cough CME

    39/59

    Why fever?

    Fever is a very energy consuming process thatevolution has preferred to persistwhy?

    It is presumed that fever improves host immune

    response:Increased mobility of leukocytes

    Enhanced leukocytes phagocytosis

    Endotoxin effects decreasedIncreased proliferation of T cells

    Those with bacterial infection are seen to have lower mortalitywhen associated with fever.

  • 8/14/2019 Pediatric Cough CME

    40/59

    Why treat fever?

    Although fever seems to be beneficial to the host, thediscomfort associated with fever eg. Malaise, headache,

    tachycardia, hypertension necessitates treating the fever.

    Certain high risk patients eg. Congenital heart diseases esp

    with LR shunt, certain metabolic disorders & those with

    H/O febrile convulsions as well as epilepsy benefit from

    controlling fevers.

    Fever controlling medications do not alter the course of the disease causing the fever

  • 8/14/2019 Pediatric Cough CME

    41/59

    Treatment of fever

    Physical methods:

    Sponging natural sweating areas of the body i.e. head,

    arms, legs, axilla & scrotum.

    Sponge with plain water or with salt or cologne added.

    Preferable to use warm water.temp body-water = 2OF

    Avoid blocking sweat pores with oil, woolen clothes.

    Keep the surroundings cool

    Keep well hydrated

    T f f

  • 8/14/2019 Pediatric Cough CME

    42/59

    Treatment of feverMedications:

    Paracetamol: aniline analgesic which is not an NSAID. Weak inhibitor ofCOX.

    Rapidly absorbed with/ without food

    Onset of action 11minutes

    Duration of action 4 hours.

    Dose related liver toxicity.

    Paracetamol in regular dosage safe in G6PD deficiency

    Ibuprofen: Nonselective COX inhibitor NSAID

    .Rapidly absorbed with/ without food

    . Rapid onset of action

    . Duration of action 8 hours

    . Because of nonselective COX inhibition G I disturbance is common.

    Ibuprofen not safe in G6PD deficiency

    Other NSAIDs

  • 8/14/2019 Pediatric Cough CME

    43/59

    Other NSAIDs

    1) NONSELECTIVE COX INHIBITORS

    - acetylsalicylic acid at high dosage

    - diclofenac - ibuprofen

    - ketoprofen

    - flurbiprofen

    - indomethacin

    - piroxicam

    - naproxen

    2) COX-1 SELECTIVE INHIBITORS - acetylsalicylic acid at low dosage

    3) MORE COX-2 SELECTIVE INHIBITORS

    - nimesulid

    - nabumeton

    4) COX-2 SELECTIVE INHIBITORS

    - celecoxib

    - etorcoxib -

  • 8/14/2019 Pediatric Cough CME

    44/59

    Commonly used drugs in coughand cold preparations

  • 8/14/2019 Pediatric Cough CME

    45/59

    Chlorpheniramine maleate

    Class - Antihistamines

    Antihistaminic action :

    Blocks the action of histamine (a substance causes

    allergic symptoms)

    Promptly relieves symptoms in Rhinitis (sneezing,

    itching of eyes, nose & throat)

    Anticholinergic action:

    reduce secretion - Rhinorrhoea

  • 8/14/2019 Pediatric Cough CME

    46/59

    Chlorpheniramine maleate

    Chlorpheniramine relieves

    Red, itchy, watery eyes

    Sneezing

    Itchy nose or throat

    Runny nose (Rhinorrhoea)

    Chlorpheniramine helps control the symptoms of

    Common Cold

  • 8/14/2019 Pediatric Cough CME

    47/59

    Phenylephrine Hydrochloride

    Nasal Decongestant

    Decongestants are the drugs of choice for a

    stuffy, congested nose

    Decongestants act by narrowing the blood

    vessels in the nose, leading to decreasedblood flow in the nasal tissues and reduced

    leakage of fluid from the nose

  • 8/14/2019 Pediatric Cough CME

    48/59

    Phenylephrine Hydrochloride

    Nasal Decongestant

    Direct Sympathomimetic

    Selective alpha1 agonist action

    Act on alpha adrenergic receptors in the mucosa of

    the respiratory tract producing vasoconstriction

    which results in shrinkage of swollen mucus

    Relieves Stuffy Congested Nose

  • 8/14/2019 Pediatric Cough CME

    49/59

    Paracetamol

    Paracetamolis one of the most popular andwidely used drugs for the treatment of pain and

    fever

    Central Analgesic Actionraises pain

    threshold

    Anti-pyretic action

    Good safety profile

    Relieves fever, sore throat and body ache

    N h i f A ti f

  • 8/14/2019 Pediatric Cough CME

    50/59

    Newer mechanism of Action for

    Paracetamol

    Cananbinoids have a role in modulation of

    pain (decrease the pain)

    Active metabolite of PCM goes and bind to

    cannabinoid receptor

    Analgesic effect of paracetamolis due to the indirect activation ofcannabinoid CB(1) receptors

    CNS Drug Rev.2006 Fall-Winter;12(3-4):250-75.

    http://www.ncbi.nlm.nih.gov/pubmed/17227290http://www.ncbi.nlm.nih.gov/pubmed/17227290http://www.ncbi.nlm.nih.gov/pubmed/17227290
  • 8/14/2019 Pediatric Cough CME

    51/59

    Caffeine

    Methyl xanthine alkaloid

    Consumed as beverages

    CNS Stimulant primarily affect the higher centers

    Produces

    Sense of well being,

    Alertness,

    Beats bordem,

    Allays fatigue,

    Improve performance

  • 8/14/2019 Pediatric Cough CME

    52/59

    Sales Training

    Dextromethorphan Hydrobromide

    (DMR)

    Non - narcotic cough suppressant (anti tussive).

    Acts centrally on cough centre, (Medulla) andelevates the threshold for coughing.

    Equipotent to codeine in depressing cough reflex.

    D t th h

  • 8/14/2019 Pediatric Cough CME

    53/59

    Sales Training

    Dextromethorphan

    Hydrobromide (DMR)

    Average dose is 10 to 30 mg 3 to 6 timesdaily.

    Has no expectoration action and does not

    inhibit ciliary action. Rapidly absorbed from

    G.I. Tract.

    Exerts effect within 15-30 minutes after oral

    administration.

    Duration of action is 5-6 hours.

    Metabolized in the liver.

  • 8/14/2019 Pediatric Cough CME

    54/59

    Sales Training

    Cough suppressants with

    equipotent doses

    Dextromethorphan 10 mg

    Codeine 15 mg Noscapine 15 mg

    Pholcodeine 10 mg

  • 8/14/2019 Pediatric Cough CME

    55/59

    Favorable Features of

    Dextromethorphan Hydrobromide

    Equipotent antitussive to Codeine,

    Pholcodiene which are narcotic.

    No addictive properties.

    Does not cause CNS depression nor it

    affects respiratory rate.

    Sales Training

  • 8/14/2019 Pediatric Cough CME

    56/59

    Sales Training

    Favorable Features of

    Dextromethorphan Hydrobromide

    Does not cause drowsiness, constipation

    unlike codeine.

    Is safe & effective.

  • 8/14/2019 Pediatric Cough CME

    57/59

    Sales Training

    Guaiphenesin

    Most commonly used expectorant.

    Often used singly or in combination.

    Readily absorbed from GI tract

    Increases the output of respiratory tract fluids, this

    helps to liquefy the thick mucus.

    Though not a cough suppressant reduces the intensityand frequency of dry or productive cough.

  • 8/14/2019 Pediatric Cough CME

    58/59

    Sales Training

    Reference

    Guaiphenesin

    From a study in 239 patients it wasreported that Guaiphenesin reduced cough

    intensity and frequency in patient with dry or

    productive cough and helped to thin

    sputum.

    RE Robinson et al, Robins, Curr ther Research, 1977 : 22 ;

    284

  • 8/14/2019 Pediatric Cough CME

    59/59

    Thank you